Bain Capital Life Sciences Investors as of Dec. 31, 2025
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 19 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heartflow Inc/Sh (HTFL) | 27.8 | $363M | 12M | 29.15 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 19.6 | $256M | 7.3M | 35.08 | |
| Olema Pharmaceuticals (OLMA) | 16.3 | $213M | 8.5M | 25.00 | |
| Savara (SVRA) | 8.1 | $106M | 18M | 6.03 | |
| Pharvaris N V (PHVS) | 6.0 | $78M | 2.8M | 27.75 | |
| Solid Biosciences Com New (SLDB) | 3.4 | $45M | 7.9M | 5.64 | |
| Upstream Bio (UPB) | 2.8 | $36M | 1.3M | 27.15 | |
| X4 Pharmaceuticals Com New (XFOR) | 2.4 | $32M | 8.0M | 4.00 | |
| Dianthus Therapeutics (DNTH) | 2.3 | $31M | 744k | 41.21 | |
| Kyverna Therapeutics (KYTX) | 2.2 | $29M | 3.1M | 9.40 | |
| Annexon (ANNX) | 2.0 | $26M | 5.2M | 5.02 | |
| Rapid Micro Biosystems Class A Com (RPID) | 1.9 | $25M | 8.4M | 2.90 | |
| Cabaletta Bio (CABA) | 1.6 | $21M | 9.7M | 2.19 | |
| C4 Therapeutics Com Stk (CCCC) | 1.0 | $14M | 7.2M | 1.91 | |
| Mersana Therapeutics (MRSN) | 0.8 | $10M | 347k | 28.93 | |
| Atea Pharmaceuticals (AVIR) | 0.7 | $8.9M | 2.5M | 3.57 | |
| Tango Therapeutics (TNGX) | 0.4 | $5.8M | 654k | 8.86 | |
| Xilio Therapeutics (XLO) | 0.4 | $4.7M | 7.4M | 0.64 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.2 | $2.3M | 100k | 23.00 |
